-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: keymaster@town.hall.org Originator-Key-Asymmetric: MFkwCgYEVQgBAQICAgADSwAwSAJBALeWW4xDV4i7+b6+UyPn5RtObb1cJ7VkACDq pKb9/DClgTKIm08lCfoilvi9Wl4SODbR1+1waHhiGmeZO8OdgLUCAwEAAQ== MIC-Info: RSA-MD5,RSA, rhwy8XFzqp3i7LG2zEWW8E/IyZZdm/hKdpnBKcshft9RacpudydysNM+THlbPXFi NoH+KyJ2dEqH49inuAmXVw== 0000277795-94-000007.txt : 19940407 0000277795-94-000007.hdr.sgml : 19940407 ACCESSION NUMBER: 0000277795-94-000007 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19940406 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: AVEMCO CORP CENTRAL INDEX KEY: 0000008802 STANDARD INDUSTRIAL CLASSIFICATION: 6331 IRS NUMBER: 520733935 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 34 SEC FILE NUMBER: 005-19598 FILM NUMBER: 94520551 BUSINESS ADDRESS: STREET 1: 411 AVIATION WAY CITY: FREDERICK STATE: MD ZIP: 21701 BUSINESS PHONE: 3016945700 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: GEICO CORP CENTRAL INDEX KEY: 0000277795 STANDARD INDUSTRIAL CLASSIFICATION: 6331 IRS NUMBER: 521135801 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: GEICO PLZ CITY: WASHINGTON STATE: DC ZIP: 20076 BUSINESS PHONE: 3019862027 SC 13G/A 1 13-G AMENDMENT 1 TO NATIONAL HEALTH LAB. INC UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Amendment No. )* Under the Securities Exchange Act of 1934 National Health Laboratories, Inc. ______________________________________ (Name of Issuer) Common Stock ______________________________________ (Title of Class of Securities) 63633F-10-9 ______________________________________ (CUSIP Number) Check the following box if a fee is being paid with this statement X. (A fee is not required only if the filing person: (1) has a previous statement on file reporting beneficial ownership of more than five percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent thereto reporting beneficial ownership of five percent or less of such class.) (See Rule 13d-7). *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 4 pages CUSIP NO. 63633F-10-9 1. NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON GEICO Corporation 52-1135801 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) ____ (b) ____ 3. SEC USE ONLY 4. CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF 5. SOLE VOTING POWER SHARES 5,500,000 BENEFICIALLY OWNED BY 6. SHARED VOTING POWER EACH - 0 - REPORTING PERSON 7. SOLE DISPOSITIVE POWER WITH 5,500,000 8. SHARED DISPOSITIVE POWER - 0 - 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 5,500,000 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES* 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9 6.20% 12. TYPE OF REPORTING PERSON* HC *SEE INSTRUCTION BEFORE FILLING OUT Page 2 of 4 pages SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 Item 1. (a) Name of Issuer: National Health Laboratories, Inc. (b) Address of Issuer's Principal 7590 Fay Avenue Executive Offices: La Jolla, California 92037 Item 2. (a) Name of Person Filing: GEICO Corporation (b) Address of Principal GEICO Plaza Business Office: Washington, D.C. 20076 (c) Citizenship: Delaware (d) Title of Class of Common Stock Securities: (e) CUSIP No.: 63633F-10-9 Item 3. The person filing is a: Parent Holding Company Item 4. Ownership* (a) Amount Beneficially owned: 5,500,000 Shares (b) Percent of Class: 6.20% (c) Number of (i) Sole power to vote or to shares as direct the vote: 5,500,000 to which such person (ii) Shared power to vote or to has: direct the vote: -0- (iii) Sole power to dispose or to direct the disposition of: 5,500,000 (IV) Shared power to dispose or to direct the disposition of: -0- * The number of shares beneficially owned and the percentage ownership are as of December 31, 1993. Page 3 or 4 pages Item 5. Ownership of 5 Percent or Less of a Class: N/A Item 6. Ownership of More than 5 Percent on Behalf of N/A Another Person: Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company: N/A Item 8. Identification and Classification of Members of the Group: N/A Item 9. Notice of Dissolution of Group: N/A Item 10. Certification. By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired for the purpose of and do not have the effect of changing or influencing the control of the issuer of such securities and were not acquired in connection with or as a participant in any transaction having such purpose or effect. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in the statement is true, complete and correct. GEICO Corporation By: /s/ Charles R. Davies Charles R. Davies Vice President and General Counsel Date: February 14, 1994 Charles R. Davies, Vice President and General Counsel Page 4 of 4 pages -----END PRIVACY-ENHANCED MESSAGE-----